@CUCancerCenter

Official X page of the University of Colorado Anschutz Cancer Center - Colorado's only @theNCI-designated comprehensive cancer center.

 Aurora, Colo.
coloradocancercenter.org
Joined October 2008
  • Tweets25.3K
  • Following1.4K
  • Followers9.9K
18.2KMedia
Today's 3rd Annual Lobular Breast Cancer Awareness Day in Colorado event brought together patients, educators, researchers, and advocacy partners from across the Front Range. 🩷 Learn all about the second most common type of breast cancer here: bit.ly/4B9nPer
Group photo of attendees and organizers in Nighthorse Campbell Building.

ALT Group photo of attendees and organizers in Nighthorse Campbell Building.

Lt. Governor Dianne Primavera, and Matthew Sikora, PhD.

ALT Lt. Governor Dianne Primavera, and Matthew Sikora, PhD.

Attendees watch the current presentation.

ALT Attendees watch the current presentation.

One of Sikora's lab students and their poster.

ALT One of Sikora's lab students and their poster.

1
149
What can Pope Leo XIV’s surgery tell us about lung cancer diagnosis and treatment? CU Anschutz Cancer Center member Elizabeth A. David, MD, MAS, answers this question and more: news.cuanschutz.edu/cancer-c…
A photo of Pope Leo XIV on a background this is off-white. There is a CU gold square behind the photo as well with a line through it. There is a grid as well towards the top left.

ALT A photo of Pope Leo XIV on a background this is off-white. There is a CU gold square behind the photo as well with a line through it. There is a grid as well towards the top left.

1
2
360
"The truth is that the face of breast cancer is the face of an older adult,” says CU Anschutz Cancer Center’s associate director of global oncology, Enrique Soto Pérez de Celis (@EnriqueSoto8), MD, PhD: bit.ly/4dGzEPf

Older Women with Breast Cancer Face Treatment and Research Gaps

Breast cancer strikes far more often after age 50, yet the needs of older patients aren’t always met, says a CU Anschutz Cancer Center geriatric oncologist.

news.cuanschutz.edu
2
2
293
Overseen by CU Anschutz Cancer Center's Bennett Chin, MD, a new theranostics suite at @uchealth University of Colorado Hospital will streamline treatment and clinical trials for certain types of cancer, notably prostate cancer and neuroendocrine tumors: bit.ly/3TNjX25
Bennett Chin, MD, and colleagues celebrating the opening of the Theranostics Suite.

ALT Bennett Chin, MD, and colleagues celebrating the opening of the Theranostics Suite.

3
317
CU Anschutz Cancer Center member Alessandra Brambati, PhD, has received a National Institutes of Health (@NIH) Director’s New Innovator Award to build the molecular tools needed to study RNA-templated repair: news.cuanschutz.edu/medicine…

2 Early-Career CU Anschutz Researchers Granted NIH Director’s New Innovator Award

The awards fund critical biomedical research that is high-risk, high reward and aims to help answer some of health science’s biggest questions.

news.cuanschutz.edu
4
260
Did you enter the Shark Tank? 🦈 🔬 On Tuesday, the Molecular and Cellular Oncology (MCO) Program offered basic scientists an opportunity to share their latest research findings in a Shark Tank-style presentation with Q&A from investigators and members of the cancer center.
The Shark Tank panel having fun. Some of them are making fins above their heads.

ALT The Shark Tank panel having fun. Some of them are making fins above their heads.

The Shark Tank panel listening.

ALT The Shark Tank panel listening.

The Shark Tank panel talking before the next presenter.

ALT The Shark Tank panel talking before the next presenter.

A scientist presents to the Shark Tank.

ALT A scientist presents to the Shark Tank.

5
360
“Dr. Lieu always has my family’s best interests in mind, and we have a great deal of trust in him," says Ross Matthews. Read about Matthews' six-year journey with stage 4 colorectal cancer and why he has participated in clinical research at @CUAnschutz: bit.ly/4iZC8vE
Ross Matthews in his living room sitting in a chair. He's smiling for the camera.

ALT Ross Matthews in his living room sitting in a chair. He's smiling for the camera.

1
176
CU Anschutz Cancer Center retweeted
manalikamdar@mana1981Oct 2
Looking forward to this year’s Lymphoma Research Foundation Educational Forum! Honored to co-chair the program and excited for two days of meaningful education, discussion, and updates for our lymphoma community. Hope you can join us! @lymphoma @WomenInLymphoma @CUCancerCenter
Lymphoma Research Foundation@lymphomaOct 2
The Educational Forum is a virtual two-day conference with important information about diagnosis and treatment, clinical trials, research advances and how to manage their disease. Date: Sat. Oct 10 – Sun. Oct 11 Find more info and register: bit.ly/4hdNA47
3
5
216
The CU Anschutz Cancer Center is the only location in the Rocky Mountains actively recruiting for the EvoPAR-Breast01 worldwide clinical trial. Cancer center's Marie Wood, MD, is the @CUAnschutz site principal investigator, learn more: bit.ly/4nTAEU6

CU Anschutz Cancer Center Joins a Global Clinical Trial of Breast Cancer Treatments

A CU Anschutz Cancer Center member is recruiting women with advanced breast cancer for a worldwide clinical trial investigating a pair of new therapies.

news.cuanschutz.edu
1
2
286
CU Anschutz Cancer Center member Allison L’Hotta, OTD, OTR/L, PhD, received funding from @theNCI to pilot an electronic health record integration strategy for symptom screening and management in children undergoing cancer treatment: bit.ly/4dck6m9
A photo of a doctor and a young patient in a circle frame. The photo is the top layer over a background that is CU gold on top and white on the bottom. There is a line drawn behind the circle frame.

ALT A photo of a doctor and a young patient in a circle frame. The photo is the top layer over a background that is CU gold on top and white on the bottom. There is a line drawn behind the circle frame.

1
4
212
For Prostate Cancer Awareness Month, CU Anschutz Cancer Center's David Strauss (@SteinStraussen), MD, and Jan Lowery, PhD, MPH, talk how screening has changed for the disease over the years and what the future may look like: news.cuanschutz.edu/cancer-c…

The Evolving ‘Who’ and ‘When’ of Prostate Cancer Screening

Prostate cancer is the most common cancer among U.S. men, and rates vary among different groups. When to get screened depends on who’s getting screened.

news.cuanschutz.edu
5
5
367
CU Anschutz Cancer Center retweeted
OncoNexus
@Onco_NexusSep 29
What were the most important SCLC developments at #WCLC 2026? @TejasPatilMD, of @CUCancerCenter, highlights three areas: 🔹 MAVERICK: MRI surveillance may be ready to replace routine prophylactic cranial irradiation for many patients with SCLC, given the lack of a clear survival or cognitive failure-free survival advantage with PCI in the modern imaging era. 🔹 B7-H3 ADCs: Phase 3 data suggest these agents could challenge topotecan’s long-standing role in relapsed SCLC and provide a more effective cytotoxic treatment strategy. 🔹 LB2102: Early phase 1 data for this DLL3-targeted CAR T-cell therapy point to a potential relationship between pre-infusion lymphocyte counts, IL-15 levels, and response, although the findings remain exploratory. Dr. Patil’s perspective offers a concise look at the SCLC studies most likely to influence practice and shape the next generation of treatment strategies. Watch: oncologynexus.com/conference… @IASLC @lungoncdoc

Dr. Tejas Patil on Key SCLC Data and Emerging Therapies at WCLC 2026 - oncologynexus.com

Tejas Patil, MD, of the University of Colorado Cancer Center, reviews key small cell lung cancer updates from WCLC 2026, including SWOG S1827 MAVERICK and the evolving role of prophylactic cranial...

oncologynexus.com
2
4
176
CU Anschutz Cancer Center's Rebecca Schweppe, PhD, Bryan Haugen, MD, and Jennifer Richer, PhD, received a $1.75 million grant from the DOD to translate their research into a new treatment for thyroid cancers that resist standard medications: bit.ly/4hJfHcS
From left: Jennifer Richer, Bryan Haugen, and Rebecca Schweppe

ALT From left: Jennifer Richer, Bryan Haugen, and Rebecca Schweppe

4
303
The family of Ian Shelton, PhD, which has deep CU ties, is providing major philanthropic support for an acute myeloid leukemia (AML) clinical trial run by CU Anschutz Cancer Center member Andrew Kent, MD, PhD: news.cuanschutz.edu/cancer-c…
Andrew Kent, MD, PhD, and Ian Shelton, PhD, in the Anschutz Health Sciences Building.

ALT Andrew Kent, MD, PhD, and Ian Shelton, PhD, in the Anschutz Health Sciences Building.

2
3
373
CU Anschutz Cancer Center's Theresa Medina, MD, provides insight into what impact the Keytruda-intismeran combination may have for high-risk melanoma patients ⬇️ uchealth.org/today/mrna-canc…

Clinical trials: New mRNA cancer vaccine plus Keytruda sharply improves melanoma survival

A personalized melanoma vaccine developed by Moderna and Merck, used with Keytruda, greatly reduced melanoma recurrence risk in trials.

uchealth.org
2
226
Congratulations to Wells Messersmith, MD, the new director of the CU Anschutz Cancer Center. See the full statement: bit.ly/4yiL1oE
"New Director of the CU Anschutz Cancer Center" in smaller text, broken up by a line of CU gold dots with larger text "Wells Messersmith, MD". There is a cutout photo of Messersmith to the right, with a CU gold dotted background behind him. The CU Anschutz Cancer Center logo is in the bottom left.

ALT "New Director of the CU Anschutz Cancer Center" in smaller text, broken up by a line of CU gold dots with larger text "Wells Messersmith, MD". There is a cutout photo of Messersmith to the right, with a CU gold dotted background behind him. The CU Anschutz Cancer Center logo is in the bottom left.

2
7
2
35
3,286
The @AACR's 2026 Cancer Progress Report highlights the latest progress in the fight against cancer. CU Anschutz Cancer Center leader James DeGregori, PhD, shares his thoughts as a member of the report's steering committee: news.cuanschutz.edu/cancer-c…
A photo of James DeGregori, PhD, to the left. Then a photo of the cover of the AACR Cancer Progress Report 2026 in the middle. To the bottom right, is a photo of cancer ribbons. The background is CU gold on the left and then white to the right.

ALT A photo of James DeGregori, PhD, to the left. Then a photo of the cover of the AACR Cancer Progress Report 2026 in the middle. To the bottom right, is a photo of cancer ribbons. The background is CU gold on the left and then white to the right.

1
2
267
CU Anschutz Cancer Center retweeted
CU Anschutz Lymphoma Program@CULymphomaSep 18
Check out the @VJHemOnc #podcast for an interview with our @CULymphoma lead Dr. @mana1981 on use of BTK inhibitors in NHL. #lymsm @CUCancerCenter @CUDeptMedicine @CUAnschutz
VJHemOnc
@VJHemOncSep 16
Want practical advice on using BTK inhibitors in clinical practice across #NonHodgkinLymphoma subtypes? 🩺 Make sure to check out our podcast episode with Manali Kamdar (@mana1981) to learn about: 🩸 Selecting patients for BTKi therapy 🩸 Adverse event counseling & management 🩸 Response monitoring & treatment at progression Listen NOW: 👉 ow.ly/IU0Z50ZMx5G #Lymphoma #LYMsm #MantleCellLymphoma #DLBCL #HemOnc @CULymphoma @CUMedicalSchool
1
2
5
485
📸 from Cancer League Colorado's Over the Edge this morning! James DeGregori, PhD, interim director, and Mercedes Rincon, PhD, a cancer center member, rappelled down the Kimpton Claret Hotel for Colorado-based cancer research. 💛
James DeGregori, PhD, interim director of the CU Anschutz Cancer Center, and Mercedes Rincon, PhD, with one of the attendees.

ALT James DeGregori, PhD, interim director of the CU Anschutz Cancer Center, and Mercedes Rincon, PhD, with one of the attendees.

James DeGregori, PhD, interim director of the CU Anschutz Cancer Center, and Mercedes Rincon, PhD, about to rappel.

ALT James DeGregori, PhD, interim director of the CU Anschutz Cancer Center, and Mercedes Rincon, PhD, about to rappel.

James DeGregori, PhD, interim director of the CU Anschutz Cancer Center, and Mercedes Rincon, PhD

ALT James DeGregori, PhD, interim director of the CU Anschutz Cancer Center, and Mercedes Rincon, PhD

1
1
300
CU Anschutz Cancer Center's Laura Graham, MD, and Enrique Soto (@EnriqueSoto8), MD, PhD, share their thoughts on hormone therapy as a treatment for breast cancer and prostate cancer ⬇️ news.cuanschutz.edu/cancer-c…

What to Know About Hormone Therapy

Primarily used to treat breast cancer and prostate cancer hormone therapy is an effective treatment method.

news.cuanschutz.edu
1
1
293
Load more